258 related articles for article (PubMed ID: 35466690)
21. Alpha1 Na,K-ATPase and Na,K,2Cl-cotransporte/D3mit3 loci interact to increase susceptibility to salt-sensitive hypertension in Dahl S(HSD) rats.
Herrera VL; Lopez LV; Ruiz-Opazo N
Mol Med; 2001 Feb; 7(2):125-34. PubMed ID: 11471547
[TBL] [Abstract][Full Text] [Related]
22. Renoprotective effect of chronic adrenomedullin infusion in Dahl salt-sensitive rats.
Nishikimi T; Mori Y; Kobayashi N; Tadokoro K; Wang X; Akimoto K; Yoshihara F; Kangawa K; Matsuoka H
Hypertension; 2002 Jun; 39(6):1077-82. PubMed ID: 12052845
[TBL] [Abstract][Full Text] [Related]
23. Effect of mineralocorticoid receptor blockade on the renal renin-angiotensin system in Dahl salt-sensitive hypertensive rats.
Zhu A; Yoneda T; Demura M; Karashima S; Usukura M; Yamagishi M; Takeda Y
J Hypertens; 2009 Apr; 27(4):800-5. PubMed ID: 19516179
[TBL] [Abstract][Full Text] [Related]
24. Effects of sodium-glucose cotransporter-2 inhibitors and aldosterone antagonists, in addition to renin-angiotensin system antagonists, on major adverse kidney outcomes in patients with type 2 diabetes and chronic kidney disease: A systematic review and network meta-analysis.
Yang S; Zhao L; Mi Y; He W
Diabetes Obes Metab; 2022 Nov; 24(11):2159-2168. PubMed ID: 35712807
[TBL] [Abstract][Full Text] [Related]
25. Unmasking a sustained negative effect of SGLT2 inhibition on body fluid volume in the rat.
Masuda T; Watanabe Y; Fukuda K; Watanabe M; Onishi A; Ohara K; Imai T; Koepsell H; Muto S; Vallon V; Nagata D
Am J Physiol Renal Physiol; 2018 Sep; 315(3):F653-F664. PubMed ID: 29790389
[TBL] [Abstract][Full Text] [Related]
26. Vascular control of kidney epithelial transporters.
Sparks MA; Dilmen E; Ralph DL; Rianto F; Hoang TA; Hollis A; Diaz EJ; Adhikari R; Chew G; Petretto EG; Gurley SB; McDonough AA; Coffman TM
Am J Physiol Renal Physiol; 2021 Jun; 320(6):F1080-F1092. PubMed ID: 33969697
[TBL] [Abstract][Full Text] [Related]
27. Elevated BSC-1 and ROMK expression in Dahl salt-sensitive rat kidneys.
Hoagland KM; Flasch AK; Dahly-Vernon AJ; dos Santos EA; Knepper MA; Roman RJ
Hypertension; 2004 Apr; 43(4):860-5. PubMed ID: 14967839
[TBL] [Abstract][Full Text] [Related]
28. Involvement of ENaC in the development of salt-sensitive hypertension.
Pavlov TS; Staruschenko A
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F135-F140. PubMed ID: 28003189
[TBL] [Abstract][Full Text] [Related]
29. Benefits and harms of sodium-glucose co-transporter-2 inhibitors (SGLT2-I) and renin-angiotensin-aldosterone system inhibitors (RAAS-I) versus SGLT2-Is alone in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials.
Seidu S; Kunutsor SK; Topsever P; Khunti K
Endocrinol Diabetes Metab; 2022 Jan; 5(1):e00303. PubMed ID: 34636161
[TBL] [Abstract][Full Text] [Related]
30. Hydronephrosis is associated with elevated plasmin in urine in pediatric patients and rats and changes in NCC and γ-ENaC abundance in rat kidney.
Zachar R; Al-Mashhadi A; Dimke H; Svenningsen P; Jensen BL; Carlström M
Am J Physiol Renal Physiol; 2018 Sep; 315(3):F547-F557. PubMed ID: 29767556
[TBL] [Abstract][Full Text] [Related]
31. Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats.
Bayorh MA; Mann G; Walton M; Eatman D
Clin Exp Hypertens; 2006 Feb; 28(2):121-32. PubMed ID: 16546838
[TBL] [Abstract][Full Text] [Related]
32. Diuretic Effects of Sodium Glucose Cotransporter 2 Inhibitors and Their Influence on the Renin-Angiotensin System.
Ansary TM; Nakano D; Nishiyama A
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717173
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of apical sodium-chloride cotransporter and basolateral chloride channels is responsible for the maintenance of salt-sensitive hypertension.
Capasso G; Rizzo M; Garavaglia ML; Trepiccione F; Zacchia M; Mugione A; Ferrari P; Paulmichl M; Lang F; Loffing J; Carrel M; Damiano S; Wagner CA; Bianchi G; Meyer G
Am J Physiol Renal Physiol; 2008 Aug; 295(2):F556-67. PubMed ID: 18480177
[TBL] [Abstract][Full Text] [Related]
34. Na
Yamauchi T; Doi S; Nakashima A; Doi T; Sohara E; Uchida S; Masaki T
Am J Physiol Renal Physiol; 2018 Aug; 315(2):F300-F312. PubMed ID: 29631358
[TBL] [Abstract][Full Text] [Related]
35. Is renal ß-adrenergic-WNK4-NCC pathway important in salt hypertension of Dahl rats?
Zicha J; Hojná S; Vaňourková Z; Kopkan L; Vaněčková I
Physiol Res; 2019 Dec; 68(6):873-882. PubMed ID: 31647304
[TBL] [Abstract][Full Text] [Related]
36. Caffeine intake antagonizes salt sensitive hypertension through improvement of renal sodium handling.
Yu H; Yang T; Gao P; Wei X; Zhang H; Xiong S; Lu Z; Li L; Wei X; Chen J; Zhao Y; Arendshorst WJ; Shang Q; Liu D; Zhu Z
Sci Rep; 2016 May; 6():25746. PubMed ID: 27173481
[TBL] [Abstract][Full Text] [Related]
37. Sex differences in solute transport along the nephrons: effects of Na
Hu R; McDonough AA; Layton AT
Am J Physiol Renal Physiol; 2020 Sep; 319(3):F487-F505. PubMed ID: 32744084
[TBL] [Abstract][Full Text] [Related]
38. Regulation of Na+ excretion and arterial blood pressure by purinergic signalling intrinsic to the distal nephron: consequences and mechanisms.
Mironova E; Boiko N; Bugaj V; Kucher V; Stockand JD
Acta Physiol (Oxf); 2015 Jan; 213(1):213-21. PubMed ID: 25154328
[TBL] [Abstract][Full Text] [Related]
39. A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats.
Durak A; Olgar Y; Degirmenci S; Akkus E; Tuncay E; Turan B
Cardiovasc Diabetol; 2018 Nov; 17(1):144. PubMed ID: 30447687
[TBL] [Abstract][Full Text] [Related]
40. ELABELA antagonizes intrarenal renin-angiotensin system to lower blood pressure and protects against renal injury.
Xu C; Wang F; Chen Y; Xie S; Sng D; Reversade B; Yang T
Am J Physiol Renal Physiol; 2020 May; 318(5):F1122-F1135. PubMed ID: 32174138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
